149 related articles for article (PubMed ID: 26653678)
1. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.
Da Silva DM; Woodham AW; Naylor PH; Egan JE; Berinstein NL; Kast WM
J Interferon Cytokine Res; 2016 May; 36(5):291-301. PubMed ID: 26653678
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.
Da Silva DM; Woodham AW; Rijkee LK; Skeate JG; Taylor JR; Koopman ME; Brand HE; Wong MK; McKee GM; Salazar AM; Kast WM
Papillomavirus Res; 2015 Dec; 1():12-21. PubMed ID: 26665182
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.
Da Silva DM; Woodham AW; Skeate JG; Rijkee LK; Taylor JR; Brand HE; Muderspach LI; Roman LD; Yessaian AA; Pham HQ; Matsuo K; Lin YG; McKee GM; Salazar AM; Kast WM
Clin Immunol; 2015 Dec; 161(2):197-208. PubMed ID: 26360252
[TBL] [Abstract][Full Text] [Related]
4. Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
Fahey LM; Raff AB; Da Silva DM; Kast WM
J Immunol; 2009 Mar; 182(5):2919-28. PubMed ID: 19234187
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.
Da Silva DM; Movius CA; Raff AB; Brand HE; Skeate JG; Wong MK; Kast WM
Virology; 2014 Mar; 452-453():279-86. PubMed ID: 24606705
[TBL] [Abstract][Full Text] [Related]
6. T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.
Woodham AW; Yan L; Skeate JG; van der Veen D; Brand HH; Wong MK; Da Silva DM; Kast WM
Papillomavirus Res; 2016 Dec; 2():21-30. PubMed ID: 27182559
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.
Woodham AW; Raff AB; Raff LM; Da Silva DM; Yan L; Skeate JG; Wong MK; Lin YG; Kast WM
J Immunol; 2014 May; 192(10):4748-57. PubMed ID: 24719459
[TBL] [Abstract][Full Text] [Related]
8. IRX-2 increases the T cell-specific immune response to protein/peptide vaccines.
Naylor PH; Hernandez KE; Nixon AE; Brandwein HJ; Haas GP; Wang CY; Hadden JW
Vaccine; 2010 Oct; 28(43):7054-62. PubMed ID: 20708999
[TBL] [Abstract][Full Text] [Related]
9. IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro.
Egan JE; Quadrini KJ; Santiago-Schwarz F; Hadden JW; Brandwein HJ; Signorelli KL
J Immunother; 2007 Sep; 30(6):624-33. PubMed ID: 17667526
[TBL] [Abstract][Full Text] [Related]
10. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
Sasagawa T; Takagi H; Makinoda S
J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
[TBL] [Abstract][Full Text] [Related]
11. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.
Polak ME; Newell L; Taraban VY; Pickard C; Healy E; Friedmann PS; Al-Shamkhani A; Ardern-Jones MR
J Invest Dermatol; 2012 Jun; 132(6):1636-44. PubMed ID: 22377764
[TBL] [Abstract][Full Text] [Related]
12. Binding of human papilloma virus L1 virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation.
de Witte L; Zoughlami Y; Aengeneyndt B; David G; van Kooyk Y; Gissmann L; Geijtenbeek TB
Immunobiology; 2007; 212(9-10):679-91. PubMed ID: 18086370
[TBL] [Abstract][Full Text] [Related]
13. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of HPV-like particle-activated Langerhans cells in vitro.
Yan L; Woodham AW; Da Silva DM; Kast WM
Methods Mol Biol; 2015; 1249():333-50. PubMed ID: 25348318
[TBL] [Abstract][Full Text] [Related]
15. Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells.
Lenz P; Lowy DR; Schiller JT
Eur J Immunol; 2005 May; 35(5):1548-56. PubMed ID: 15832296
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M; Schinz M; Zumbach K; Pawlita M; Schneider A; Dürst M; Kaufmann AM
J Cancer Res Clin Oncol; 2003 Sep; 129(9):511-20. PubMed ID: 12905010
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation.
Fausch SC; Fahey LM; Da Silva DM; Kast WM
J Immunol; 2005 Jun; 174(11):7172-8. PubMed ID: 15905561
[TBL] [Abstract][Full Text] [Related]
18. Immunological function of Langerhans cells in HIV infection.
Matsuzawa T; Ogawa Y; Moriishi K; Shimada S; Kawamura T
J Dermatol Sci; 2017 Aug; 87(2):159-167. PubMed ID: 28433429
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.
Iijima N; Goodwin EC; Dimaio D; Iwasaki A
Virology; 2013 Sep; 444(1-2):257-62. PubMed ID: 23871219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
